Navin Fluorine International on Tuesday said it has commenced commercial production at Dewas, Madhya Pradesh, from January 6, to create additional cGMP capacity. The Dewas facility is the hub of its CRAMS activities. In December, the board of Navin had approved a capital expenditure programme at Dahej (Gujarat) through a wholly-owned subsidiary at an estimated capital outlay of ₹450 crore over the next three-four years. Investors will closely monitor developments.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.